Loomis, Sayles & Company’s Utah Medical Products UTMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-330
| Closed | -$22K | – | 748 |
|
|
2024
Q2 | $22K | Sell |
330
-14,547
| -98% | -$970K | ﹤0.01% | 669 |
|
|
2024
Q1 | $1.06M | Sell |
14,877
-29,562
| -67% | -$2.1M | ﹤0.01% | 459 |
|
|
2023
Q4 | $3.74M | Sell |
44,439
-1,589
| -3% | -$134K | 0.01% | 419 |
|
|
2023
Q3 | $3.96M | Sell |
46,028
-4,154
| -8% | -$357K | 0.01% | 406 |
|
|
2023
Q2 | $4.68M | Sell |
50,182
-1,338
| -3% | -$125K | 0.01% | 402 |
|
|
2023
Q1 | $4.88M | Sell |
51,520
-884
| -2% | -$83.8K | 0.01% | 402 |
|
|
2022
Q4 | $5.27M | Sell |
52,404
-450
| -0.9% | -$45.2K | 0.01% | 372 |
|
|
2022
Q3 | $4.51M | Sell |
52,854
-5,548
| -9% | -$473K | 0.01% | 366 |
|
|
2022
Q2 | $5.02M | Sell |
58,402
-354
| -0.6% | -$30.4K | 0.01% | 399 |
|
|
2022
Q1 | $5.28M | Sell |
58,756
-1,857
| -3% | -$167K | 0.01% | 415 |
|
|
2021
Q4 | $6.06M | Sell |
60,613
-935
| -2% | -$93.5K | 0.01% | 411 |
|
|
2021
Q3 | $5.71M | Sell |
61,548
-124
| -0.2% | -$11.5K | 0.01% | 419 |
|
|
2021
Q2 | $5.24M | Buy |
61,672
+21,302
| +53% | +$1.81M | 0.01% | 417 |
|
|
2021
Q1 | $3.5M | Sell |
40,370
-2,007
| -5% | -$174K | ﹤0.01% | 430 |
|
|
2020
Q4 | $3.57M | Sell |
42,377
-838
| -2% | -$70.7K | ﹤0.01% | 428 |
|
|
2020
Q3 | $3.45M | Buy |
43,215
+5,498
| +15% | +$439K | 0.01% | 405 |
|
|
2020
Q2 | $3.34M | Buy |
37,717
+5,545
| +17% | +$491K | 0.01% | 409 |
|
|
2020
Q1 | $3.03M | Sell |
32,172
-18,334
| -36% | -$1.72M | 0.01% | 418 |
|
|
2019
Q4 | $5.45M | Sell |
50,506
-3,035
| -6% | -$327K | 0.01% | 407 |
|
|
2019
Q3 | $5.13M | Sell |
53,541
-7,932
| -13% | -$760K | 0.01% | 403 |
|
|
2019
Q2 | $5.88M | Sell |
61,473
-2,381
| -4% | -$228K | 0.01% | 395 |
|
|
2019
Q1 | $5.64M | Buy |
63,854
+603
| +1% | +$53.2K | 0.01% | 410 |
|
|
2018
Q4 | $5.25M | Buy |
63,251
+5,205
| +9% | +$432K | 0.01% | 413 |
|
|
2018
Q3 | $5.47M | Buy |
+58,046
| New | +$5.47M | 0.01% | 464 |
|